164 related articles for article (PubMed ID: 34675316)
1. ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression.
Ma K; Chen X; Liu W; Yang Y; Chen S; Sun J; Ma C; Wang T; Yang J
Sci Rep; 2021 Oct; 11(1):20839. PubMed ID: 34675316
[TBL] [Abstract][Full Text] [Related]
2. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas.
Ma K; Chen S; Chen X; Yang C; Yang J
World Neurosurg; 2022 Sep; 165():e650-e663. PubMed ID: 35779750
[TBL] [Abstract][Full Text] [Related]
3. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma.
Li X; Nie S; Lv Z; Ma L; Song Y; Hu Z; Hu X; Liu Z; Zhou G; Dai Z; Song T; Liu J; Wang S
Cell Death Dis; 2021 Mar; 12(3):261. PubMed ID: 33712571
[TBL] [Abstract][Full Text] [Related]
5. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
[TBL] [Abstract][Full Text] [Related]
6. Annexin A2 regulates glioma cell proliferation through the STAT3‑cyclin D1 pathway.
Chen L; Lin L; Xian N; Zheng Z
Oncol Rep; 2019 Jul; 42(1):399-413. PubMed ID: 31115554
[TBL] [Abstract][Full Text] [Related]
7. EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study.
Hao Z; Guo D
BMC Cancer; 2019 Dec; 19(1):1184. PubMed ID: 31801484
[TBL] [Abstract][Full Text] [Related]
8. [The expression and significance of ANXA2 in human glioma].
Lu ZQ; Gao YL; Lu JX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):787-9. PubMed ID: 21033036
[TBL] [Abstract][Full Text] [Related]
9. Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas.
Li S; Zou H; Shao YY; Mei Y; Cheng Y; Hu DL; Tan ZR; Zhou HH
Oncotarget; 2017 Dec; 8(63):106962-106975. PubMed ID: 29291003
[TBL] [Abstract][Full Text] [Related]
10. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
11. Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.
Liu F; Huang J; Xiong Y; Li S; Liu Z
Aging (Albany NY); 2019 Aug; 11(15):5463-5482. PubMed ID: 31377744
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
[TBL] [Abstract][Full Text] [Related]
13. Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma.
Yuan Y; Zhao Q; Zhao S; Zhang P; Zhao H; Li Z; Du Y; Tian X; Lu J
Cancer Med; 2019 Jul; 8(8):3811-3821. PubMed ID: 31140757
[TBL] [Abstract][Full Text] [Related]
14. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
[TBL] [Abstract][Full Text] [Related]
16. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance.
Yang SF; Hsu HL; Chao TK; Hsiao CJ; Lin YF; Cheng CW
Urol Oncol; 2015 Jan; 33(1):22.e11-22.e21. PubMed ID: 25284003
[TBL] [Abstract][Full Text] [Related]
18. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion.
Ma Y; Wang H
Sci Rep; 2021 Mar; 11(1):5033. PubMed ID: 33658625
[TBL] [Abstract][Full Text] [Related]
20. The association of annexin A2 and cancers.
Zhang X; Liu S; Guo C; Zong J; Sun MZ
Clin Transl Oncol; 2012 Sep; 14(9):634-40. PubMed ID: 22855149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
